Zynex Deferred Long Term Liab from 2010 to 2024

ZYXI Stock  USD 8.32  0.03  0.36%   
Zynex's Deferred Long Term Liabilities is increasing with slightly volatile movements from year to year. Deferred Long Term Liabilities is predicted to flatten to about 2.3 M. Deferred Long Term Liabilities is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. View All Fundamentals
 
Deferred Long Term Liabilities  
First Reported
2010-12-31
Previous Quarter
2.9 M
Current Value
2.3 M
Quarterly Volatility
418 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Zynex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zynex's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.4 M, Interest Expense of 1.1 M or Total Revenue of 193.5 M, as well as many indicators such as Price To Sales Ratio of 2.0, Dividend Yield of 0.0 or PTB Ratio of 7.97. Zynex financial statements analysis is a perfect complement when working with Zynex Valuation or Volatility modules.
  
Check out the analysis of Zynex Correlation against competitors.

Latest Zynex's Deferred Long Term Liab Growth Pattern

Below is the plot of the Deferred Long Term Liab of Zynex Inc over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Zynex's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zynex's overall financial position and show how it may be relating to other accounts over time.
Deferred Long Term Liab10 Years Trend
Slightly volatile
   Deferred Long Term Liab   
       Timeline  

Zynex Deferred Long Term Liab Regression Statistics

Arithmetic Mean2,342,083
Geometric Mean2,301,026
Coefficient Of Variation17.85
Mean Deviation320,264
Median2,526,000
Standard Deviation418,039
Sample Variance174.8B
Range1.3M
R-Value0.67
Mean Square Error103.5B
R-Squared0.45
Significance0.01
Slope62,696
Total Sum of Squares2.4T

Zynex Deferred Long Term Liab History

20242.3 M
20232.9 M
20132.5 M

About Zynex Financial Statements

Investors use fundamental indicators, such as Zynex's Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Although Zynex's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Deferred Long Term Liabilities2.9 M2.3 M

Currently Active Assets on Macroaxis

When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock:
Check out the analysis of Zynex Correlation against competitors.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.30)
Earnings Share
0.14
Revenue Per Share
5.984
Quarterly Revenue Growth
0.001
Return On Assets
0.0399
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.